Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.

Powell Doherty RD., Liao H., Satsangi JJ., Ternette N.

DOI

10.1053/j.gastro.2020.03.073

Type

Journal article

Journal

Gastroenterology

Publication Date

07/04/2020

Addresses

Centre for Cellular and Molecular Physiology, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, Experimental Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Permalink Original publication